Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy

Journal of Clinical Virology

Volumn 42, Issue 2, 2008, Pages 211-214

  Del Prete, Raffaele ^a   Taranto, Anna Maria Di ^b   Lipsi, Maria Rosaria ^b   Nirchio, Vincenzo ^b   Antonetti, Raffaele ^b   Miragliotta, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Ospedali Riuniti di Foggia   (Italy)

Author keywords

Age; Cervical cancer; HPV infection; HPV prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION RATE; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

ADULT; COLPOSCOPY; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; VAGINAL SMEARS;

EID: 44249107555     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.01.011     Document Type: Article

References (20)

1. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87 (1995) 796-802
2. Bulkmans N.W., et al. High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer 96 9 (2007) 1419-1424
3. Centurioni M.G., Puppo A., Merlo D.F., Pasciucco G., Cusimano E.R., Sirito R., et al. Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BCM Infect Dis 5 (2005) 77
4. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M., et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84 (2001) 1616-1623
5. Coutlee F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe N., et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40 (2002) 902-907
6. Cuzick J., Beverley E., Ho L., Terry G., Sapper H., Mielzynska I., et al. HPV testing in primary screening of older women. Br J Cancer 81 (1999) 554-558
7. Galloway D.A. Papillomavirus vaccines in clinical trials. Lancet Infect Dis 3 (2003) 469-475
8. IARC Working Group, and on the Evaluation of Cancer Prevention Strategies. Cervix cancer screening vol. 10 (2005), IARC Press, Lyon, France
9. Karlsen F., Kalantari M., Jenkins A., Pettersen E., Kristensen G., Holm R., et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 34 (1996) 2095-2100
10. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsagué X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
11. Munoz N., Castelsagué X., de Gonzàles A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl. 3 (2006) S1-S10
12. Perrons C., Kleter B., Jelley R., Jalal H., Quint W., and Tedder R. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J Med Virol 67 (2002) 246-252
13. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35 (1997) 1304-1310
14. Ronco G., Ghisetti V., Segnan N., Snijders P.J., Gillo-Tos A., Meijer C.J., et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 41 (2005) 297-305
15. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., and Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324 (1986) 163-166
16. Schiffman M., and Castle P.E. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127 (2003) 930-934
17. Schiffman M., Herrero R., Hildesheim A., Sherman M.E., Bratti M., Wacholder S., et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283 (2000) 87-93
18. Steben M., and Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107 Suppl. 1 (2007) S2-S5
19. Walboomers J.M., and Meijer C.J. Do HPV-negative cervical carcinomas exist?. J Pathol 181 (1997) 253-254
20. Wikstrom A., van Doornum G.J., Quint W.G., Schiller J.T., and Dillner J. Identification of human papillomavirus seroconversion. J Gen Virol 76 (1995) 529-539